News from inspiremd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:NSPR)

Dec 15, 2014, 08:30 ET

InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced results from...

Nov 12, 2014, 16:11 ET

InspireMD Reports Financial Results for the Third Quarter ended September 30, 2014

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced its...

Nov 07, 2014, 17:20 ET

InspireMD Completes $8.1 Million Registered Direct Offering

InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in stent Embolic Protection Systems (EPS), today announced the...

Nov 05, 2014, 16:05 ET

InspireMD to Report Financial Results for the Third Quarter Ended September 30, 2014 on Wednesday, November 12th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems, announced today that it will...

Nov 04, 2014, 09:27 ET

InspireMD Announces Registered Direct Offering for Approximately $8 Million

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in stent Embolic Protection Systems (EPS), today announced that...

Oct 29, 2014, 09:06 ET

InspireMD Investigational Device Exemption (IDE) amendment approved by the FDA

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in Embolic Protection Systems (EPS), today announced that the...

Oct 14, 2014, 07:30 ET

InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid - New Product Programs

InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in stent Embolic Protection Systems (EPS), today provided...

Oct 01, 2014, 08:40 ET

InspireMD Announces Initial Commercial Sales of the CGuard™ EPS

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems (EPS), today announced that it...

Sep 18, 2014, 15:35 ET

InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), will host a live webinar and...

Sep 16, 2014, 16:10 ET

InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced positive...

Sep 03, 2014, 08:30 ET

InspireMD to Present at the Aegis Healthcare and Technology Conference

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that its...

Aug 11, 2014, 08:00 ET

InspireMD to Announce Results of CGuard™ CARENET Trial at the TCT Innovation Session on Late Breaking Early Human Clinical Studies

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that...

Jul 23, 2014, 16:05 ET

InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2014

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced its financial...

Jul 17, 2014, 08:30 ET

InspireMD to Report Financial Results for the Second Quarter Ended June 30, 2014 on Wednesday, July 23rd

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, announced today that it will release...

Jul 15, 2014, 08:30 ET

InspireMD Appoints Dr. James Barry as Chief Operating Officer

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, today announced the appointment of James...

Jul 08, 2014, 08:30 ET

InspireMD Announces Successful Completion of CGuard™ CARENET (CARotid Embolic protection study using microNET) Trial

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that it has...

Jul 01, 2014, 08:30 ET

InspireMD Selected for Inclusion in the Russell Microcap® Index

 InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, today announced that it has been...

Jun 23, 2014, 08:30 ET

InspireMD Receives European Regulatory Approval to Resume Manufacturing and Distribution of MGuard(TM) Prime EPS

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems (EPS), today announced that it...

Jun 18, 2014, 08:30 ET

InspireMD to Present at the 9th Annual JMP Securities Healthcare Conference

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo, will be presenting at the 9th Annual...

May 20, 2014, 08:30 ET

InspireMD to Showcase Embolic Systems with MicroNet™ Technology and Results from MASTER I Trial at EuroPCR Conference

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that it will be...